Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Cationic peptidomimetic amphiphiles having a N-aryl- or N-naphthyl-1,2,3-triazole core structure targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation, and an in vivo C. difficile infection model

Mahadari, M.K., Jennepalli, S., Tague, A.J., Putsathit, P., Hutton, M.L., Hammer, K.A., Knight, D.R.ORCID: 0000-0002-9480-4733, Riley, T.V., Lyras, D., Keller, P.A. and Pyne, S.G. (2021) Cationic peptidomimetic amphiphiles having a N-aryl- or N-naphthyl-1,2,3-triazole core structure targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation, and an in vivo C. difficile infection model. Antibiotics, 10 (8). Article 913.

[img]
Preview
PDF - Published Version
Download (845kB) | Preview
Free to read: https://doi.org/10.3390/antibiotics10080913
*No subscription required

Abstract

Clostridioides (also known as Clostridium) difficile is a Gram-positive anaerobic, spore producing bacterial pathogen that causes severe gastrointestinal infection in humans. The current chemotherapeutic options are inadequate, expensive, and limited, and thus inexpensive drug treatments for C. difficile infection (CDI) with improved efficacy and specificity are urgently needed. To improve the solubility of our cationic amphiphilic 1,1′-binaphthylpeptidomimetics developed earlier that showed promise in an in vivo murine CDI model we have synthesized related compounds with an N-arytriazole or N-naphthyltriazole moiety instead of the 1,1′-biphenyl or 1,1′-binaphthyl moiety. This modification was made to increase the polarity and thus water solubility of the overall peptidomimetics, while maintaining the aromatic character. The dicationic N-naphthyltriazole derivative 40 was identified as a C. difficile-selective antibacterial with MIC values of 8 µg/mL against C. difficile strains ATCC 700057 and 132 (both ribotype 027). This compound displayed increased water solubility and reduced hemolytic activity (32 µg/mL) in an in vitro hemolysis assay and reduced cytotoxicity (CC50 32 µg/mL against HEK293 cells) relative to lead compound 2. Compound 40 exhibited mild efficacy (with 80% survival observed after 24 h compared to the DMSO control of 40%) in an in vivo murine model of C. difficile infection by reducing the severity and slowing the onset of disease.

Item Type: Journal Article
Murdoch Affiliation(s): Centre for Biosecurity and One Health
Harry Butler Institute
Publisher: MDPI
Copyright: © 2021 by the authors
URI: http://researchrepository.murdoch.edu.au/id/eprint/61827
Item Control Page Item Control Page

Downloads

Downloads per month over past year